Akers stock: buy or sell?

AKER stock price: $2.97 -6.01% At close on December 6th, 2019

Updated on:
December 6th, 2019

0

Shares of Akers ended today at $2.97 and plunged a bloodcurdling -6.01%. On November/29 AKER skyrocketed a super good 15.45%. With Friday it's been 5 sliding days in a row, loosing $-4.73 (-72.66%).

Akers Biosciences, Inc., together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States and internationally.

Should I buy Akers stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to choose your own trading plan that matches with your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Akers Biosciences stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Akers stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't find any rating for AKER stock for the last 30 days.

Akers stock analysis

Daily outlook

Akers shares plunged -6.01% to $2.97 today.

Shares of Akers closed today at $2.97 and plunged a bloodcurdling -6.01%. Since price and SMA50d lines crossed down on September, AKER fell $-7.85 per share (-72.55%).

AKER stock chart (daily)

Weekly outlook

After boosting an extraordinary 9.35% in a week last week, Akers Biosciences closed this week at $2.97 and plummed a frightening -61.43%.

Akers Biosciences is sliding further to find new supports after falling under the support. Since late September, when AKER stock price broke down the 20-weeks moving avarage line, it slid $-8.96 per share (-75.10%).

AKER stock chart (weekly)

Akers stock price history

Akers stock went public on January 23rd, 2014 with a price of $1,086.721. Since then, AKER stock sliced a -99.70%, with a yearly average of -19.90%.

1: Adjusted price after possible price splits or reverse-splits.

Akers stock historical price chart

AKER stock reached 52-week highs on January at $36.96, and all-time highs 2014-01-23 with a price of 1094.4.

Akers stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' AKER stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we have not found any price prediction for Akers stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since last April, when Akers presented its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will extend this review.
AKER earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/an/an/a
2017-Q2-n/an/an/a
2017-Q32017-11-15n/a-0.13n/a
2017-Q42018-04-03n/a-0.23n/a
2018-Q12018-07-13n/a-0.03n/a
2018-Q22018-08-14n/a-0.02n/a
2018-Q32018-11-15n/a-0.26n/a
2018-Q42019-04-01n/a-0.34n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Akers annual turnover plummed a scary -50.35% to $1.67 M USD from $3.35 marked in 2017. When comparing 2018 vs 2017, likewise, profit margin (that is, the net income divided by revenues) plummed a -431.79% to -651.37%.

AKER annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2012$1.52 M-$-2.45 M-161.2%-
2013$3.58 M135.53%$-1.53 M-42.7%-37.55%
2014$4.43 M23.66%$-3.13 M-70.6%104.39%
2015$2.12 M-52.23%$-9.31 M-440.3%197.77%
2016$2.96 M39.99%$-3.30 M-111.6%-64.52%
2017$3.35 M13.30%$-7.37 M-219.6%122.98%
2018$1.67 M-50.35%$-10.85 M-651.4%47.28%

Quarterly financial results

Akers reported $0.28 million in revenues for 2018-Q4, a -49.85% less compared to previous quarter. Reported quarter earnings marked $-3.84 million with a profit margin of -1,373.50%. Profit margin collapsed a -819.92% compared to previous quarter when profit margin was -553.58%. When comparing revenues to same quarter last year, Akers Biosciences sales marked a frightening slide and plunged a -70.24%.
AKER quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$0.67 M-$-1.35 M-202.3%-
2017-Q2$1.07 M60.36%$-0.82 M-76.4%-39.41%
2017-Q3$0.68 M-36.84%$-1.18 M-174.3%43.96%
2017-Q4$0.94 M38.91%$-4.02 M-428.4%241.48%
2018-Q1$0.30 M-67.78%$-1.86 M-614.9%-53.75%
2018-Q2$0.53 M74.10%$-2.07 M-392.6%11.15%
2018-Q3$0.56 M5.79%$-3.08 M-553.6%49.17%
2018-Q4$0.28 M-49.85%$-3.84 M-1373.5%24.44%

Akers ownership

When you are planning to invest in a stock, it's always worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Akers, 0.23% of all outstanding shares are owned by its staff.

In case of Akers Biosciences stock, 8.40% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for AKER stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related stocks:

AKER
Market cap$1.5 M
Total shares0.5 M
Float shares0.5 M
  - Institutional holdings (%)8.4%
  - Insider holdings (%)0.2%
Shares in short selling0.0%

Akers summary

Friday, December 6th, 2019
Open$3.00
Close$2.97
Day range$2.75 - $3.08
Previous close$3.16
Session gain-6.01%
Average true range$1.05
50d mov avg$8.47
100d mov avg$9.62
200d mov avg$13.81
Daily pattern
Weekly pattern lt01c

Akers performance

To measure stock performance is always good to benchmark with competitors or related stocks. We picked as the bechmarking frame for Akers stock.
Stock3m6m12m
AKERAkers Biosciences-72.14%-76.01%-90.97%

Akers competitors

Unfortunately, we could not find any public company that could be defined as Akers competitor. This doesn't mean Akers does not have any competitor in the market, it's just we could not detected it.